E-Folder
#1 in Business Subscribe Email Print

You are here: Home > Business > Business > Continuous Improvement - PDCA - The CHECK Phase

Tags

  • phase
  • where
  • patients
  • companies involved
  • combination products
  • continuous improvement

  • Links

  • Champagne Gift Baskets
  • Starting a Business With Reprint Rights Products
  • Modify Clipart for Unique Results
  • E-Folder - Continuous Improvement - PDCA - The CHECK Phase

    Let's start with our reminder of... "What is an improvement cycle?"

    Make Continuous Improvement One Of Your Goals - As Soon As You Possibly Can (ID: 74077)

    What Is An Improvement Cycle?

    "Everything we do is a process, every process has a customer
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    "

    The Improvement Cycle is a highly disciplined and rigorous approach to problem solving using the Plan, Do, Check, Act (PDCA) methodology developed by Dr. W. Edwards Deming.

    The Improvement Cycle consists of seven steps, 3 in the Plan phase, 1 in
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    the Do phase, 1 in the Check phase, and 2 in the Act phase.

    The PDCA cycle needs to be used in a continuous manner, select your theme or project, assess the current situation, plan and implement your solutions, check the effects of your cha
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    nges, standardise on your new improved process, and plan for future improvements – the cycle continues.

    ---SIDEBAR---

    Although a certain amount of value and benefit may be derived from implementing part of the PDCA improvement process, a far great
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    er benefit will be achieved by sticking to the process and following all 4 phases as best you can. this is especially important when involving internal and/or external team members.

    Apart from getting the chance to read the main article (ID: 74077)
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    I hope you have also read and understood the importance of the PLAN and DO phases

    "Continuous Improvement - PDCA - The PLAN Phase (ID: 76694)"
    "Continuous Improvement - PDCA - The DO Phase (ID: 78506)"



    - If you missed them, please t
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ake the time to read them first, then come back.

    ---END SIDEBAR---

  • We have a PLAN and trust it
  • we implement the plan (DO)
  • we CHECK whether its working or not
  • if not, we fix it (ACT)
  • if it's workin
  • easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    g, we standardise on improvement (ACT)

    Are you ready to check your results?

    What is it that makes PDCA get its results?

    For me the answer to that is twofold...

  • As a problem solving/decision making process it is as powerful helpin
  • nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    g individuals, groups or whole organizations minimize the risk in starting a new project or opportunity as it is in identifying root cause problems and facilitating the means by which we can fix them.



  • Secondly, where progress meeti
  • and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ngs or even plans themselves come to a standstill because of supposition, conjecture and even emotion (not to be confused with passion which is a totally different animal altogether), PDCA gives us the focus and the discipline through the CHECKIN
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    phase to analyse the data and base future decisions and actions based on that data.



    Ask yourself, will I know, for definite, what the root cause of my success or lack of success actually is?

    If You (and your team) developed the p
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    lan of action, if you implemented that plan, if you gathered data over the agreed period of time against each of the measures that were set, then you are now ready to check what has happened and why it has happened.

    After an agreed a
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    mount of time, check the data you have been gathering, what results did you achieve, are you getting the desired results?

    N.B. Always check like with like, comparing your original data with new data gathered after you implemented the changes.

    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    STEP 5 Study Your Results

  • Monitor progress as defined in your plan

    - Are you following your plan? If not, why not?
    - Are you gathering data against your performance measures?
    - Are results being communicated effectivel
  • tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    y?
    - Is each change being documented?
    - Do you know exactly why you're getting what you're getting?

  • Gather and analyze more data if necessary
  • What are your measures telling you?
  • Are you on track or n
  • t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    t? Would you know?
  • Are you getting the results you wanted?


  • NOTE: Depending on the number of changes made and the number of countermeasures implemented, your results may well be mixed. Some successful, some not.

    This is the
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    basis of CONTINUOUS IMPROVEMENT. Because the PDCA model is being followed we have a number of choices we can make now. For example...

    If results are positive, if the problem or issue has been fixed, or the project/opportunity has been suc
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    cessful – go forward to
    Phase 4, Step 6 - ACT

    Please Note... Steps 6 and 7 of the Fourth Phase of PDCA, the ACT phase, will follow shortly in the next article.

    If results are not as you expected, depending on what your data analy
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    sis and comparisons are telling you, you may need to return to
    Phase 2, Step 4 - DO. "Continuous Improvement - PDCA - The DO Phase (ID: 78506)"

    However, if your analysis reveals a serious shortfall in results, you may need to return to<
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    br>Phase 1, Step 2 - PLAN. "Continuous Improvement - PDCA - The PLAN Phase (ID: 76694)"

    TRUST THE DATA

    "What we see depends mainly on what we look for."


    Sir John Lubbock

    =================================================


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-folder.org.ua/article/4413/e-folder-Continuous-Improvement--PDCA--The-CHECK-Phase.html">Continuous Improvement - PDCA - The CHECK Phase</a>

    BB link (for phorums):
    [url=http://www.e-folder.org.ua/article/4413/e-folder-Continuous-Improvement--PDCA--The-CHECK-Phase.html]Continuous Improvement - PDCA - The CHECK Phase[/url]

    Related Articles:

    Why You Need a Business Plan for Your Cleaning Company

    What NASA Can Teach You About Your Business Goals

    Quality Church Sound Systems

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com